NOX 2.86% 7.2¢ noxopharm limited

Ann: Licencing Deal Expands Noxopharm Drug Opportunities, page-9

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    Harvett, I salute you for your imagination.

    So, according to you, Noxopharm plucked the Licence deal with Hudson Institute out of thin air, as a PR stunt? Get real!
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.